Article

Akorn launches generic antibiotic formulations

Buffalo Grove, IL—Now that patents have expired on two popular antibiotics, Akorn Inc. has launched generic versions of Alcon's Ciloxan and Ocuflox.

Buffalo Grove, IL-Now that patents have expired on two popular antibiotics, Akorn Inc. has launched generic versions of Alcon's Ciloxan and Ocuflox.

Ciprofloxacin ophthalmic solutions USP, 0.3%, and ofloxacin ophthalmic solution USP, 0.3%, were launched in the U.S. market in May. The company anticipates the combined market potential for both products to be more than $40 million.

The new products will be marketed through the company's existing distribution channels.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) CCOI sets the stage for global ophthalmic innovation at Stanford Summit on July 23
(Image credit: Ophthalmology Times) Accelerating eye health innovation through CCOI – Stanford Summit
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game (Part 2)
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game? (Part 1)
© 2025 MJH Life Sciences

All rights reserved.